Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
AbbVie
ABBV
|
+$239M |
| 2 |
Otis Worldwide
OTIS
|
+$156M |
| 3 |
Verizon
VZ
|
+$145M |
| 4 |
Baidu
BIDU
|
+$139M |
| 5 |
Carrier Global
CARR
|
+$135M |
Top Sells
| 1 |
Apple
AAPL
|
+$381M |
| 2 |
Amazon
AMZN
|
+$358M |
| 3 |
Bank of America
BAC
|
+$265M |
| 4 |
AGN
Allergan plc
AGN
|
+$259M |
| 5 |
Wells Fargo
WFC
|
+$241M |
Sector Composition
| 1 | Technology | 16.42% |
| 2 | Financials | 16.29% |
| 3 | Industrials | 12.58% |
| 4 | Healthcare | 11.61% |
| 5 | Consumer Discretionary | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2951
OR Royalties Inc.
OR
$6.59B
| $953K | ﹤0.01% |
95,274
+3,100
| +3% | +$31K |
|
2952
Atlantic American Corp
AAME
$65.7M
| $952K | ﹤0.01% |
580,204
-3,707
| -0.6% | -$6.08K |
|
2953
Coca-Cola Europacific Partners
CCEP
$41.6B
| $949K | ﹤0.01% |
25,165
+1,173
| +5% | +$44.2K |
|
|
EIGR
2954
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $941K | ﹤0.01% |
3,266
+723
| +28% | +$208K |
|
2955
Amneal Pharmaceuticals
AMRX
$3.06B
| $940K | ﹤0.01% |
197,462
+186,590
| +1,716% | +$888K |
|
2956
Veritone
VERI
$212M
| $938K | ﹤0.01% |
63,138
-2,990
| -5% | -$44.4K |
|
2957
LGL Group
LGL
$35.7M
| $934K | ﹤0.01% |
291,505
| – | – |
|
|
CLPR
2958
Clipper Realty
CLPR
$71.4M
| $928K | ﹤0.01% |
114,610
+10,080
| +10% | +$81.6K |
|
2959
Lantronix
LTRX
$187M
| $924K | ﹤0.01% |
248,948
-9,461
| -4% | -$35.1K |
|
|
AENZ
2960
DELISTED
Aenza S.A.A. American Depositary Shares (each representing fifteen (15) Common Shares)
AENZ
| $924K | ﹤0.01% |
140,455
-3,597
| -2% | -$23.7K |
|
2961
ORIX
IX
$29.8B
| $923K | ﹤0.01% |
74,915
-45,305
| -38% | -$558K |
|
2962
Clear Channel Outdoor Holdings
CCO
$666M
| $921K | ﹤0.01% |
885,355
-293,876
| -25% | -$306K |
|
|
TBIO
2963
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $921K | ﹤0.01% |
51,404
-2,115
| -4% | -$37.9K |
|
2964
RCM Technologies
RCMT
$203M
| $920K | ﹤0.01% |
686,389
-116,915
| -15% | -$157K |
|
2965
Flanigan's Enterprises
BDL
$53.4M
| $917K | ﹤0.01% |
62,199
-286
| -0.5% | -$4.22K |
|
2966
Pro-Dex
PDEX
$116M
| $916K | ﹤0.01% |
51,429
+1,328
| +3% | +$23.7K |
|
|
MIXT
2967
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $914K | ﹤0.01% |
106,021
| – | – |
|
2968
CrowdStrike
CRWD
$106B
| $910K | ﹤0.01% |
9,078
-153
| -2% | -$15.3K |
|
|
MFGP
2969
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $906K | ﹤0.01% |
165,393
-222,654
| -57% | -$1.22M |
|
2970
Red Violet
RDVT
$715M
| $900K | ﹤0.01% |
51,028
| – | – |
|
2971
Zynex
ZYXI
$44.2M
| $894K | ﹤0.01% |
39,549
+2,737
| +7% | +$61.9K |
|
2972
Hudbay
HBM
$5.15B
| $887K | ﹤0.01% |
292,661
+19,319
| +7% | +$58.6K |
|
2973
Plumas Bancorp
PLBC
$314M
| $885K | ﹤0.01% |
40,001
| – | – |
|
2974
Princeton Bancorp
BPRN
$223M
| $884K | ﹤0.01% |
44,011
+1,201
| +3% | +$24.1K |
|
2975
Aldeyra Therapeutics
ALDX
$342M
| $874K | ﹤0.01% |
209,577
+14,650
| +8% | +$61.1K |
|